Difference between revisions of "Template:Analgesics"
Jump to navigation
Jump to search
blackwiki>Sizeofint (INN) |
|||
| Line 11: | Line 11: | ||
| group1 = [[Opiate]]s/[[opium]] | | group1 = [[Opiate]]s/[[opium]] | ||
| list1 = | | list1 = | ||
| − | * [[Codeine]]<sup>#</sup> | + | * [[Codeine]]<sup>#</sup> ([[co-codamol|+paracetamol]], [[co-codaprin|+aspirin]]) |
| − | * [[Morphine]]<sup>#</sup> | + | * [[Morphine]]<sup>#</sup> ([[morphine/naltrexone|+naltrexone]]) |
* [[Opium]] | * [[Opium]] | ||
* [[Laudanum]] | * [[Laudanum]] | ||
| Line 21: | Line 21: | ||
* [[Acetyldihydrocodeine]] | * [[Acetyldihydrocodeine]] | ||
* [[Benzylmorphine]] | * [[Benzylmorphine]] | ||
| − | * [[Buprenorphine]] | + | * [[Buprenorphine]] ([[buprenorphine/naloxone|+naloxone]]) |
* [[Desomorphine]] | * [[Desomorphine]] | ||
* [[Heroin|Diamorphine (heroin)]] | * [[Heroin|Diamorphine (heroin)]] | ||
| − | * [[Dihydrocodeine]] | + | * [[Dihydrocodeine]] ([[co-dydramol|+paracetamol]]) |
* [[Dihydromorphine]] | * [[Dihydromorphine]] | ||
* [[Ethylmorphine]] | * [[Ethylmorphine]] | ||
| − | * [[Hydrocodone]] | + | * [[Hydrocodone]] ([[hydrocodone/paracetamol|+paracetamol]], [[hydrocodone/ibuprofen|+ibuprofen]]) |
* [[Hydromorphinol]] | * [[Hydromorphinol]] | ||
* [[Hydromorphone]] | * [[Hydromorphone]] | ||
| Line 33: | Line 33: | ||
* [[Nicodicodeine]] | * [[Nicodicodeine]] | ||
* [[Nicomorphine]] | * [[Nicomorphine]] | ||
| − | * [[Oxycodone]] | + | * [[Oxycodone]] ([[oxycodone/paracetamol|+paracetamol]], [[oxycodone/aspirin|+aspirin]], [[oxycodone/ibuprofen|+ibuprofen]], [[oxycodone/naloxone|+naloxone]], [[oxycodone/naltrexone|+naltrexone]]) |
| − | |||
* [[Oxymorphone]] | * [[Oxymorphone]] | ||
* [[Thebacon]] | * [[Thebacon]] | ||
| Line 46: | Line 45: | ||
* [[Dextropropoxyphene]] | * [[Dextropropoxyphene]] | ||
* [[Dezocine]] | * [[Dezocine]] | ||
| − | * [[Fentanyl]] | + | * [[Fentanyl]] ([[fentanyl/fluanisone|+fluanisone]]) |
* [[Ketobemidone]] | * [[Ketobemidone]] | ||
* [[Levorphanol]] | * [[Levorphanol]] | ||
| Line 65: | Line 64: | ||
}} | }} | ||
| − | | group2 = [[ | + | | group2 = [[Paracetamol]]-type |
| list2 = | | list2 = | ||
* [[Acetanilide]]<sup>‡</sup> | * [[Acetanilide]]<sup>‡</sup> | ||
| Line 151: | Line 150: | ||
* [[Tetrahydrocannabinol|Tetrahydrocannabinol (dronabinol)]] | * [[Tetrahydrocannabinol|Tetrahydrocannabinol (dronabinol)]] | ||
| − | | group5 = [[ | + | | group5 = [[Ion channel modulator|Ion channel<br />modulator]]s |
| list5 = {{Navbox|child | | list5 = {{Navbox|child | ||
| liststyle = width: auto; | | liststyle = width: auto; | ||
| Line 170: | Line 169: | ||
* [[Nefopam]] | * [[Nefopam]] | ||
* [[Tricyclic antidepressant]]s (e.g., [[amitriptyline]]<sup>#</sup>) | * [[Tricyclic antidepressant]]s (e.g., [[amitriptyline]]<sup>#</sup>) | ||
| + | |||
| + | * ''Na<sub>v</sub>1.7/1.8-selective:'' [[DSP-2230]]<sup>§</sup> | ||
| + | * [[Funapide]]<sup>§</sup> | ||
| + | * [[PF-05089771]]<sup>§</sup> | ||
| + | * [[Raxatrigine]]<sup>§</sup> | ||
| group3 = [[Potassium channel opener|Potassium openers]] | | group3 = [[Potassium channel opener|Potassium openers]] | ||
Revision as of 06:22, 29 August 2016
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Analgesics|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Analgesics|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Analgesics|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.